日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells

更正:丙戊酸与Aurora激酶抑制剂VE465联合用药对妇科癌细胞的细胞毒性作用增强

Li, Yanfang; Liu, Tao; Ivan, Cristina; Huang, Jie; Shen, De-Yu; Kavanagh, John J; Bast, Robert C Jr; Fu, Siqing; Hu, Wei; Sood, Anil K

Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells

丙戊酸与Aurora激酶抑制剂VE465联合用药对妇科癌细胞的细胞毒性作用增强

Li, Yanfang; Liu, Tao; Ivan, Cristina; Huang, Jie; Shen, De-Yu; Kavanagh, John J; Bast, Robert C Jr; Fu, Siqing; Hu, Wei; Sood, Anil K

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.

培利福新联合多西他赛治疗铂类和紫杉烷类耐药或难治性高级别上皮性卵巢癌患者

Fu Siqing, Hennessy Bryan T, Ng Chaan S, Ju Zhenlin, Coombes Kevin R, Wolf Judith K, Sood Anil K, Levenback Charles F, Coleman Robert L, Kavanagh John J, Gershenson David M, Markman Maurie, Dice Kristine, Howard Adrienne, Li Jane, Li Yang, Stemke-Hale Katherine, Dyer Mary, Atkinson Edward, Jackson Ed, Kundra Vikas, Kurzrock Razelle, Bast Robert C Jr, Mills Gordon B

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

一项 1b-2a 期研究旨在通过使用低甲基化药物阿扎胞苷逆转铂类耐药性,治疗铂类耐药或铂类难治性上皮性卵巢癌患者。

Fu, Siqing; Hu, Wei; Iyer, Revathy; Kavanagh, John J; Coleman, Robert L; Levenback, Charles F; Sood, Anil K; Wolf, Judith K; Gershenson, David M; Markman, Maurie; Hennessy, Bryan T; Kurzrock, Razelle; Bast, Robert C Jr

Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension

Cyp1a1-Ren2 大鼠集合管肾素和肾素原受体增强可能参与恶性高血压的发生发展

Minolfa C Prieto, Dustyn E Williams, Liu Liu, Kimberly L Kavanagh, John J Mullins, Kenneth D Mitchell

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer

一项评估坎福酰胺联合聚乙二醇化脂质体阿霉素治疗铂类和紫杉醇难治性或耐药性上皮性卵巢癌的II期研究

Kavanagh, John J; Levenback, Charles F; Ramirez, Pedro T; Wolf, Judith L; Moore, Carla L; Jones, Marsha R; Meng, Lisa; Brown, Gail L; Bast, Robert C Jr

Update on aurora kinase inhibitors in gynecologic malignancies

妇科恶性肿瘤中极光激酶抑制剂的最新进展

Tao, Xia; Chon, Hye S; Fu, Siqing; Kavanagh, John J; Hu, Wei

Ovarian cancer, the coagulation pathway, and inflammation

卵巢癌、凝血途径和炎症

Wang, Xipeng; Wang, Ena; Kavanagh, John J; Freedman, Ralph S